Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;112:3211

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles

(Circulation. 2005;112:3211.)
© 2005 American Heart Association, Inc.

Issue Highlights


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    ANTICOAGULATION THERAPY IN ATRIAL FIBRILLATION IN COMBINATION WITH ACUTE MYOCARDIAL INFARCTION INFLUENCES LONG-TERM OUTCOME: A PROSPECTIVE COHORT STUDY FROM THE REGISTER OF INFORMATION AND KNOWLEDGE ABOUT SWEDISH HEART INTENSIVE CARE ADMISSIONS (RIKS-HIA), by Stenestrand et al.
 
Atrial fibrillation (AF) is a common arrhythmia after myocardial infarction (MI). Because of the widespread use of aspirin in patients recovering from MI and the increasing use of clopidogrel when a stent is implanted, it is useful to have information on the safety of the combination of aspirin, clopidogrel, and warfarin in patients with AF after MI. Investigators in Sweden report in this issue a prospective cohort study from a registry of intensive care unit admissions. The use of oral anticoagulants in patients with AF was associated with a significant reduction in 1-year mortality and was superior to antiplatelet therapy alone. An accompanying editorial (see p 3212) places this important report in perspective alongside the ACC/AHA Guidelines on management of patients with STEMI and adds support for the use of dual antiplatelet therapy in combination with oral anticoagulation in patients with AF after MI. See p 3225.


*    DIETARY {alpha}-LINOLENIC ACID INTAKE AND RISK OF SUDDEN CARDIAC DEATH AND CORONARY HEART DISEASE, by Albert et al.
 
The majority of women who die suddenly do not have an antecedent history of heart disease. Dietary interventions that are suitable for use in large populations offer potential means to reduce these deaths. Intake of long-chain n-3 fatty acids found in fish have been associated with reduced sudden death. The intermediate-chain n-3 fatty acid a-linolenic acid (ALA), which is found in plants, has antiarrhythmic effects in animal models, and a small portion is converted to long-chain n-3 fatty acids. The impact of ALA intake on cardiovascular outcomes was investigated in 76 763 women enrolled in the Nurses’ Health Study. Increasing ALA intake . . . [Full Text of this Article]


Related Articles:

Anticoagulation Therapy in Atrial Fibrillation in Combination With Acute Myocardial Infarction Influences Long-Term Outcome: A Prospective Cohort Study From the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA)
Ulf Stenestrand, Johan Lindbäck, Lars Wallentin for the RIKS-HIA Registry
Circulation 2005 112: 3225-3231. [Abstract] [Full Text]

Dietary {alpha}-Linolenic Acid Intake and Risk of Sudden Cardiac Death and Coronary Heart Disease
Christine M. Albert, Kyungwon Oh, William Whang, JoAnn E. Manson, Claudia U. Chae, Meir J. Stampfer, Walter C. Willett, and Frank B. Hu
Circulation 2005 112: 3232-3238. [Abstract] [Full Text]

Metabolic Modulation With Perhexiline in Chronic Heart Failure: A Randomized, Controlled Trial of Short-Term Use of a Novel Treatment
Leong Lee, Ross Campbell, Michaela Scheuermann-Freestone, Rachel Taylor, Prasad Gunaruwan, Lynne Williams, Houman Ashrafian, John Horowitz, Alan G. Fraser, Kieran Clarke, and Michael Frenneaux
Circulation 2005 112: 3280-3288. [Abstract] [Full Text]

Unusual Case of Pheochromocytoma With a Surprising Response to the Intravenous Administration of Norepinephrine
Jan Pesek, Vladislav Treska, Jiri Ferda, and Petr Mukensnabl
Circulation 2005 112: e327-e328. [Extract] [Full Text]

Cardiac Metastasis: Visualization With Positron Emission Tomography, Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography/Computed Tomography, and Positron Emission Tomography/Magnetic Resonance Imaging
Marcus D. Seemann and Jochen Gaa
Circulation 2005 112: e329-e330. [Extract] [Full Text]

Serial Changes of the Electrocardiogram During the Progression of Subarachnoidal Hemorrhage
Moriaki Inoko, Junji Nakashima, Tetsuya Haruna, Kimisato Nakano, Tetsuhiko Yanazume, Eisaku Nakane, Toru Kinugawa, Hisataka Ohwaki, Masatsune Ishikawa, and Ryuji Nohara
Circulation 2005 112: e331-e332. [Extract] [Full Text]

Letter Regarding Article by Koch et al, "Impact of Prothesis–Patient Size on Functional Recovery After Aortic Valve Replacement" Response
Philippe Pibarot, Jean G. Dumesnil, Giordano Tasca, Colleen Gorman Koch, Farah Khandwala, Fawzy G. Estafanous, Floyd D. Loop, and Eugene H. Blackstone
Circulation 2005 112: e333. [Extract] [Full Text]